Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022 - 2023)
Abeona Therapeutics' (ABEO) quarterly Asset Writedowns and Impairment came in at -$1.2 million in Q2 2023, down 2887.18% year-on-year from $41798.5 in Q2 2022, and down 1265.0% quarter-over-quarter from $100000.0 in Q1 2023.
Abeona Therapeutics (ABEO) Asset Writedowns and Impairment (2022 - 2023) Analysis & Trends
Abeona Therapeutics' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at -$1.2 million for Q2 2023.
- On a quarterly basis, Asset Writedowns and Impairment fell 2887.18% year-over-year to -$1.2 million in Q2 2023; TTM through Dec 2023 was -$1.1 million, a 176.07% decrease from a year earlier, with the FY2023 full-year figure at -$1.1 million, down 176.07% from the prior year.
- Asset Writedowns and Impairment fell to -$1.2 million in Q2 2023 per ABEO's latest filing, from $100000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.6 million in Q1 2022 and bottomed at -$1.2 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.17 Mn |
| Jun 30, 2023 | -1.17 Mn |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Sep 30, 2022 | -206,000.00 |
| Sep 30, 2022 | -206,000.00 |
| Jun 30, 2022 | -39,000.00 |
| Jun 30, 2022 | -39,000.00 |
| Mar 31, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |